Cargando…
Acceptability of a COVID-19 Vaccine among the Saudi Population
To investigate the associated factors underlying vaccination intentions for Coronavirus Disease 2019 (COVID-19), an online cross-sectional survey was conducted among adults 18 years or over in the Kingdom of Saudi Arabia. Data were collected between 8 and 14 December 2020. A logistic regression anal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999879/ https://www.ncbi.nlm.nih.gov/pubmed/33807732 http://dx.doi.org/10.3390/vaccines9030226 |
_version_ | 1783670881719943168 |
---|---|
author | Alfageeh, Eman Ibrahim Alshareef, Noor Angawi, Khadijah Alhazmi, Fahad Chirwa, Gowokani Chijere |
author_facet | Alfageeh, Eman Ibrahim Alshareef, Noor Angawi, Khadijah Alhazmi, Fahad Chirwa, Gowokani Chijere |
author_sort | Alfageeh, Eman Ibrahim |
collection | PubMed |
description | To investigate the associated factors underlying vaccination intentions for Coronavirus Disease 2019 (COVID-19), an online cross-sectional survey was conducted among adults 18 years or over in the Kingdom of Saudi Arabia. Data were collected between 8 and 14 December 2020. A logistic regression analysis was employed to examine and identify the variables associated with vaccination intentions for COVID-19, with the odds ratio (OR) and 95% confidence interval (CI) also calculated. A total of 2137 respondents completed the questionnaire. Overall, about 48% of Saudi adults were willing to receive the COVID-19 vaccine. Participants had stronger intentions to receive a vaccination if they resided in the southern region (OR: 1.95; 95% CI: 1.21–3.14), received the seasonal influenza vaccination in the past (OR: 1.52; 95% CI: 1.17–1.97), believed in mandatory COVID-19 vaccination (OR: 45.07; 95% CI: 31.91–63.65), or reported high levels of concern about contracting COVID-19 (OR: 1.91; 95% CI: 1.29–2.81). Participants were less likely to have an intention to be vaccinated if they had a history of vaccine refusal (OR: 0.28; 95% CI: 0.19–0.40). The low acceptance rate among the Saudi population should be targeted with multifaceted interventions aimed at raising awareness and emphasizing the safety and efficacy of the COVID-19 vaccine. |
format | Online Article Text |
id | pubmed-7999879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79998792021-03-28 Acceptability of a COVID-19 Vaccine among the Saudi Population Alfageeh, Eman Ibrahim Alshareef, Noor Angawi, Khadijah Alhazmi, Fahad Chirwa, Gowokani Chijere Vaccines (Basel) Article To investigate the associated factors underlying vaccination intentions for Coronavirus Disease 2019 (COVID-19), an online cross-sectional survey was conducted among adults 18 years or over in the Kingdom of Saudi Arabia. Data were collected between 8 and 14 December 2020. A logistic regression analysis was employed to examine and identify the variables associated with vaccination intentions for COVID-19, with the odds ratio (OR) and 95% confidence interval (CI) also calculated. A total of 2137 respondents completed the questionnaire. Overall, about 48% of Saudi adults were willing to receive the COVID-19 vaccine. Participants had stronger intentions to receive a vaccination if they resided in the southern region (OR: 1.95; 95% CI: 1.21–3.14), received the seasonal influenza vaccination in the past (OR: 1.52; 95% CI: 1.17–1.97), believed in mandatory COVID-19 vaccination (OR: 45.07; 95% CI: 31.91–63.65), or reported high levels of concern about contracting COVID-19 (OR: 1.91; 95% CI: 1.29–2.81). Participants were less likely to have an intention to be vaccinated if they had a history of vaccine refusal (OR: 0.28; 95% CI: 0.19–0.40). The low acceptance rate among the Saudi population should be targeted with multifaceted interventions aimed at raising awareness and emphasizing the safety and efficacy of the COVID-19 vaccine. MDPI 2021-03-05 /pmc/articles/PMC7999879/ /pubmed/33807732 http://dx.doi.org/10.3390/vaccines9030226 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Alfageeh, Eman Ibrahim Alshareef, Noor Angawi, Khadijah Alhazmi, Fahad Chirwa, Gowokani Chijere Acceptability of a COVID-19 Vaccine among the Saudi Population |
title | Acceptability of a COVID-19 Vaccine among the Saudi Population |
title_full | Acceptability of a COVID-19 Vaccine among the Saudi Population |
title_fullStr | Acceptability of a COVID-19 Vaccine among the Saudi Population |
title_full_unstemmed | Acceptability of a COVID-19 Vaccine among the Saudi Population |
title_short | Acceptability of a COVID-19 Vaccine among the Saudi Population |
title_sort | acceptability of a covid-19 vaccine among the saudi population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999879/ https://www.ncbi.nlm.nih.gov/pubmed/33807732 http://dx.doi.org/10.3390/vaccines9030226 |
work_keys_str_mv | AT alfageehemanibrahim acceptabilityofacovid19vaccineamongthesaudipopulation AT alshareefnoor acceptabilityofacovid19vaccineamongthesaudipopulation AT angawikhadijah acceptabilityofacovid19vaccineamongthesaudipopulation AT alhazmifahad acceptabilityofacovid19vaccineamongthesaudipopulation AT chirwagowokanichijere acceptabilityofacovid19vaccineamongthesaudipopulation |